Donor Site Morbidity of Patients Receiving Vertical Rectus Abdominis Myocutaneous Flap for Perineal, Vaginal or Inguinal Reconstruction.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Jan 2021
Historique:
accepted: 06 09 2020
pubmed: 1 10 2020
medline: 23 6 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

Management of donor site closure after harvesting a vertical rectus abdominis myocutaneous (VRAM) flap is discussed heterogeneously in the literature. We aim to analyze the postoperative complications of the donor site depending on the closure technique. During a 12-year period (2003-2015), 192 patients in our department received transpelvic VRAM flap reconstruction. Prospectively collected data were analyzed retrospectively. 182 patients received a VRAM flap reconstruction for malignant, 10 patients for benign disease. The median age of patients was 62 years. 117 patients (61%) received a reconstruction of donor site by Vypro® mesh, 46 patients (24%) by Vicryl® mesh, 23 patients (12%) by direct closure and 6 patients (3%) by combination of different meshes. 32 patients (17%) developed in total 34 postoperative complications at the donor site. 22 complications (11%) were treated conservatively, 12 (6%) surgically. 17 patients (9%) developed incisional hernia during follow-up, with highest incidence in the Vicryl® group (n = 8; 17%) and lowest in the Vypro® group (n = 7; 6%). Postoperative parastomal hernias were found in 30 patients (16%) including three patients with simultaneous hernia around an urostomy and a colostomy. The highest incidence of parastomal hernia was found in patients receiving primary closure of the donor site (n = 6; 26%), the lowest incidence in the Vypro® group (n = 16; 14%). The use of Vypro® mesh for donor site closure appears to be associated with a low postoperative incidence of complications and can therefore be recommended as a preferred technique.

Sections du résumé

BACKGROUND BACKGROUND
Management of donor site closure after harvesting a vertical rectus abdominis myocutaneous (VRAM) flap is discussed heterogeneously in the literature. We aim to analyze the postoperative complications of the donor site depending on the closure technique.
METHODS METHODS
During a 12-year period (2003-2015), 192 patients in our department received transpelvic VRAM flap reconstruction. Prospectively collected data were analyzed retrospectively.
RESULTS RESULTS
182 patients received a VRAM flap reconstruction for malignant, 10 patients for benign disease. The median age of patients was 62 years. 117 patients (61%) received a reconstruction of donor site by Vypro® mesh, 46 patients (24%) by Vicryl® mesh, 23 patients (12%) by direct closure and 6 patients (3%) by combination of different meshes. 32 patients (17%) developed in total 34 postoperative complications at the donor site. 22 complications (11%) were treated conservatively, 12 (6%) surgically. 17 patients (9%) developed incisional hernia during follow-up, with highest incidence in the Vicryl® group (n = 8; 17%) and lowest in the Vypro® group (n = 7; 6%). Postoperative parastomal hernias were found in 30 patients (16%) including three patients with simultaneous hernia around an urostomy and a colostomy. The highest incidence of parastomal hernia was found in patients receiving primary closure of the donor site (n = 6; 26%), the lowest incidence in the Vypro® group (n = 16; 14%).
CONCLUSION CONCLUSIONS
The use of Vypro® mesh for donor site closure appears to be associated with a low postoperative incidence of complications and can therefore be recommended as a preferred technique.

Identifiants

pubmed: 32995931
doi: 10.1007/s00268-020-05788-5
pii: 10.1007/s00268-020-05788-5
pmc: PMC7752873
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-140

Références

Plast Reconstr Surg. 2010 Nov;126(5):1573-80
pubmed: 20639803
Can J Surg. 2019 Dec 01;62(6):426-435
pubmed: 31782298
Ann Plast Surg. 2016 Jan;77(1):90-2
pubmed: 25188251
Int J Colorectal Dis. 2013 Apr;28(4):503-10
pubmed: 23178992
Plast Reconstr Surg. 2018 Nov;142(5):1327-1335
pubmed: 30113449
J Plast Reconstr Aesthet Surg. 2016 Aug;69(8):1097-101
pubmed: 27221783
Ann Surg. 2013 Jun;257(6):e16
pubmed: 23665972
Front Surg. 2019 Jul 02;6:39
pubmed: 31334246
Dis Colon Rectum. 2014 May;57(5):623-31
pubmed: 24819103
Ann Surg. 2013 Dec;258(6):1007-13
pubmed: 23364701
Front Oncol. 2020 May 13;10:719
pubmed: 32477947
Ann Plast Surg. 2004 Jan;52(1):22-6
pubmed: 14676694
Gynecol Oncol. 2000 May;77(2):293-7
pubmed: 10785481
Plast Reconstr Surg. 2008 Aug;122(2):472-8
pubmed: 18626364
Plast Reconstr Surg. 2011 Aug;128(2):447-58
pubmed: 21788836
Int J Colorectal Dis. 2013 Jun;28(6):801-6
pubmed: 23053678
J Gastrointest Surg. 2014 Apr;18(4):782-8
pubmed: 24203585
Ann Surg Oncol. 2009 Jan;16(1):68-77
pubmed: 18985271
Plast Reconstr Surg. 2009 Jan;123(1):175-83
pubmed: 19116551
Int J Gynecol Cancer. 2007 Jan-Feb;17(1):298-303
pubmed: 17291272
J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):791-7
pubmed: 22264638
J Am Coll Surg. 2008 Apr;206(4):694-703
pubmed: 18387476
Plast Reconstr Surg. 2010 Jul;126(1):146-55
pubmed: 20220559
Br J Surg. 2010 Apr;97(4):588-99
pubmed: 20186891
Ann Plast Surg. 2017 Jul;79(1):101-106
pubmed: 28542071
Colorectal Dis. 2009 Oct;11(8):806-16
pubmed: 19055518
Arch Surg. 2003 Dec;138(12):1340-3
pubmed: 14662535
Int J Colorectal Dis. 2014 Jul;29(7):813-23
pubmed: 24752738
Colorectal Dis. 2013 Sep;15(9):1177-83
pubmed: 23672636
Arch Surg. 1990 Jul;125(7):911-3
pubmed: 1695088
Ann Med Surg (Lond). 2018 Dec 21;38:28-33
pubmed: 30595839
Dis Colon Rectum. 2006 Oct;49(10):1559-63
pubmed: 17120189
Ann Plast Surg. 2010 May;64(5):559-62
pubmed: 20395804

Auteurs

Vera S Schellerer (VS)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany. vera.schellerer@uk-erlangen.de.

Lenka Bartholomé (L)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Melanie C Langheinrich (MC)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Robert Grützmann (R)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Raymund E Horch (RE)

Department of Plastic Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Susanne Merkel (S)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Klaus Weber (K)

Department of Surgery, University Medical Center Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH